PCL2 modulates gene regulatory networks controlling self-renewal and commitment in embryonic stem...

©2011 Landes Bioscience.Do not distribute.

www.landesbioscience.com Cell Cycle 45

Cell Cycle 10:1, 45-51; January 1, 2011; © 2011 Landes Bioscience

extra view extra view

Key words: polycomb-like 2, jarid2, polycomb, embryonic stem cell, gene regulatory network, histone methylation

Abbreviations: PcG, polycomb group; PRC2, polycomb repressive complex 2; Pcl2, polycomb-like 2; ESC, embry-onic stem cell; GRN, gene regulatory network; TF, transcription factor; PRE, polycomb repressive element

Submitted: 12/02/10

Accepted: 12/05/10

Previously published online: www.landesbioscience.com/journals/cc/article/14389

DOI: 10.4161/cc.10.1.14389

*Correspondence to: William L. Stanford; Email: [email protected]

Recent reports have better elucidated the components of the Polycomb

Repressive Complex 2 (PRC2) and its functional role in embryonic stem cells (ESCs) and their differentiated deriva-tives. The depletion of a newly described mammalian PRC2 associated protein, PCL2, leads to an increase in ESC self-renewal and a delay in differentiation, a phenotype similar to knockouts of the core PRC2 members. Genomic and cell biology data suggest that PCL2 is important in cell fate decisions and may play a role in recruitment of PRC2 to target genes and histone methylation. Importantly, depletion of PCL2 in ESCs leads to a decrease in 3meH3K27 at the proximal promoter regions of pluripo-tency transcription factors Tbx3, Klf4, Foxd3 and a concomitant increase in gene expression. These proteins sub-sequently activate expression of Oct4, Nanog and Sox2 through a feed-forward gene regulatory circuit, altering the core pluripotency network and driving cell fate decisions towards self-renewal. We propose a model whereby alteration of the epigenetic state of Tbx3, Klf4 and Foxd3 results in the enforced expression of the pluripotency network, preventing differentiation.

Introduction

Polycomb group (PcG) proteins are known epigenetic transcriptional repres-sors that play critical roles maintaining cellular memory of fate decisions made during development. PcG proteins exist

PCL2 modulates gene regulatory networks controlling self-renewal and commitment in embryonic stem cells

Emily Walker,1,† Janet L. Manias,1,† Wing Y. Chang1,† and William L. Stanford1-4,*1Institute of Biomaterials and Biomedical Engineering; 2Institute of Medical Sciences; 3Department of Chemical Engineering and Applied Chemistry;

University of Toronto; Toronto, Ontario Canada; 4Institute for Systems Biology; Seattle, WA USA†These authors contributed equally to this work.

in two main complexes, and act to repress the expression of various target genes, including transcription factors (TFs). The Polycomb Repressive Complex 2 (PRC2) is comprised of a core group of proteins, EZH2, SUZ12 and EED1-3 and executes its repressive role by modifying chroma-tin structure via histone methylation. Specifically, EZH2 is a histone methyl-transferase, and is able to catalyze the di- and tri-methylation at H3K27. Enzymatic action by EZH2 at target genes requires the binding of SUZ12 and EED.3 Recent developments have expanded the concept of a simple three member PRC2 complex to one that includes multiple associated proteins that may interact with the PRC2 complex to modify its enzymatic function, influence its stability or contribute to its targeting.

The embryonic stem cell (ESC) pro-vides an excellent model to study the molecular mechanisms controlling cell fate. Response to internal or external stimuli leads to changes in molecular, genetic and epigenetic events which pro-vide tightly-regulated control during self-renewal and differentiation. By incor-porating genomic and proteomic datasets with cell biological events such as cell sig-naling or self-renewal, integrated gene reg-ulatory networks (GRNs) may be drafted, enabling the identification of novel inter-actions as well as identification of novel regulators (or nodes).

To better understand the molecular underpinnings of self-renewal and com-mitment of ESCs, we drafted and tested GRN modules.4 Through this analysis,


46 Cell Cycle volume 10 issue 1

While the PHD protein domain is gen-erally considered to convey DNA binding function, it has also been shown to bind RNA, proteins and lipid domains.16,17 The protein-protein interactions between PCL2 and the other PRC2 members identified by co-immunoprecipitation may be mediated through the PHD domains, although this will need to be confirmed using binding assays with dele-tion mutants. The PHD domain has also been associated with a chromatin binding, as it can specifically recognize methylated lysine residues, as observed in the NuRF protein targeting H3K4 areas.18,19 This feature may also aid in the targeting of PCL2 to its targets, since PRC2 is known to bind at highly methylated regions.

In addition to its 2 PHD domains, the two longest isoforms of PCL2 also contain a TUDOR domain (Fig. 1), which is known to aid in targeting pro-teins to methylated sites on the genome. TUDOR domains are thought to target proteins to methylated lysines during spliceosome assembly or recognition of histone tails. It may be the combination of PHD and TUDOR domains of PCL2 that function to associate with members of PRC2 and recruitment the complex to specific promoter targets based on sequence or histone modifications. Thus, each isoform of PCL2 may have specific

with PRC2 core members SUZ12, EZH2 and EED.5,12,13 The discovery of accessory proteins, such as PCL2 and JARID2, has expanded the original notion of a simple three member PRC2 complex to one that is much more complex and dynamic. While an association between JARID2 and PCL2 has been shown through mass spectrometry,12,14 there are conditions where this interaction failed to be cap-tured,13 allowing for the possibility that JARID2 and PCL2 may or may not coex-ist in the same PRC2 complex at any given time.

Protein Domains

The mechanism of PRC2 recruitment to its target genes is currently unknown and none of the core components have DNA-binding capability. Based on their protein domains, both PCL2 and JARID2 are candidates for such a role. Three distinct isoforms of PCL2 are found in ESCs, each of which shows conservation of two PHD (plant home-odomain type zinc finger) domains from Drosophila PCL (Fig. 1). JARID2 also contains a PHD domain along with an evolutionarily conserved ARID/BRIGHT domain, both of which have DNA-binding capabilities.15

we identified Polycomb-like 2 (Pcl2, also known as Mtf2) as a candidate regulator of ESC fate. Pcl2 is highly expressed in ESCs and its promoter is bound by OCT4 and NANOG, suggesting that it is regu-lated by key pluripotency factors. Further, upon commitment to differentiation, we found that Pcl2 is downregulated in a sim-ilar fashion as Oct4, Sox2 and Nanog.4 We now show in our recent study that PCL2 is critical for modulating GRNs involved in both ESC self-renewal and commitment. Our analyses show that PCL2 associates with the core components of the PRC2 complex and plays a critical role in ESC differentiation and self-renewal.5 In this Extra Views article, we highlight our pre-vious findings and propose a model of epigenetic modification by PRC2 and its associated proteins.

Association with the PRC2 Complex

It has been shown that PCL2 can associate with EZH2 in chick,6 and that PCL asso-ciates with E(Z) in Drosophila.7 PHF1, another member of the Polycomblike family was also shown to associate with PRC2 in fly and human.8-11 Similarly, our lab and others recently demonstrated by co-immunoprecipitation and mass spec-trometry that mammalian PCL2 interacts

Figure 1. Clustal w amino acid alignment of three PCL2 isoforms with PHD Zinc Finger (purple) and tUDOr (green) domains highlighted.



activity? and (3) is 3meH3K27 increased, decreased or unchanged at target promot-ers following depletion of Jarid2? It is clear that the biochemical role of JARID2 is still under debate and that the methylation pattern at target genes following deple-tion of a PRC2 accessory protein is still unknown. Further investigation into the function of PCL2 and JARID2 will help to refine any proposed model of PRC2 recruitment and epigenetic modification.

Polycomb complex formation, target recruitment and chromatin modifica-tion appear to be dynamic during ESC commitment and early differentiation. If PRC2 targets change during the course of ESC commitment to particular lineages, it is likely that more than one accessory pro-tein, along with other transcription factors and elements such as ncRNA,26 will inter-act to recruit and stabilize the PRC2 com-plex at specific locations. It has previously been suggested that a dynamic change in the stoichiometric ratio of accessory pro-teins in the PRC2 complex may influence the levels of methylation at H3K27.27 This may explain why knockdown of Jarid2 has been shown to both increase13,23 and decrease12,25 3meH3K27 at certain targets.

Perturbations of ESC Differentiation

We and others hold the general hypoth-esis that genes regulated at the onset of commitment to differentiation are critical for regulating ESC fate decisions. PRC2 members are strong candidate regulators as they are all highly expressed in undif-ferentiated ESCs and are immediately downregulated upon differentiation. Genome-wide ChIP analyses established that PRC2 binds a wide range of devel-opmental TFs.24 It was further noted that many PRC2 targets were commonly bound by OCT4, NANOG and SOX2.28 Together these observations culminated in the proposition that PRC2 cooperated with the ESC GRN to silence develop-mental targets in undifferentiated ESCs, preventing precocious differentiation. Once given the cue to differentiate, PRC2 would be downregulated, releasing repres-sion of its targets and allowing upregula-tion of developmental TFs. If this simple explanation of ESC maintenance were

Global and Specific Changes in Histone Methylation

Since PcG proteins are generally thought of as transcriptional repressors, we con-sidered whether PCL2 may have a direct effect on gene expression. To determine whether PCL2 binding results in direct transcriptional repression, we analyzed highly enriched targets of PCL2 that were downregulated in Pcl2 knockdown ESCs. Luciferase-reporter assays for Bmp2, Foxc1, Gsc, Lhx1, Pitx2, Sox1, Tbx3, Wnt3 and Oct4-reporter lines did not show any change in Luciferase level, suggesting that PCL2 does not directly modulate transcription of developmental targets (unpublished). This data led us to pos-tulate that PCL2 may act in a repressive manner through PRC2 recruitment lead-ing to epigenetic modifications.

PRC2 exerts its effect on gene expres-sion through deposition of 3meH3K27, a repressive histone modification, mediated by the enzymatic activity of EZH2. Thus, we asked whether depletion of PCL2 would result in a decrease in 3meH3K27. Although downregulation of Pcl2 in ESCs did not alter global levels of 3meH3K27, when analyzed using ChIP-qPCR we observed a reduction in 3meH3K27 at specific target genes. Importantly, at pro-moter regions of genes such as Tbx3, Klf4, T and Evx1, there was also a reduction in binding of SUZ12, EZH2 and EED, indi-cating that PCL2 may be involved in the recruitment or stabilization of PRC2 at particular targets.

In contrast, methylation data JARID2 is more difficult to interpret. It was reported that in Jarid2 null or Jarid2 knockdown ESCs, global levels of 3meH3K27 were unaffected but spe-cific targets showed a slight increase13 or decrease12 in 3meH3K27. While many groups have suggested JARID2 acts to fine-tune modulation of 3meH3K27 at PRC2 targets, there has been conflict-ing data regarding whether it inhibits13,23 or stimulates12,25 the methyltransferase activity of PRC2. Thus, several key issues remain unresolved: (1) is JARID2 respon-sible for inhibition or stimulation of PRC2 function and 3meH3K27? (2) instead, is JARID2 responsible only for the recruit-ment of PRC2 but not its enzymatic

protein- or DNA-binding targets. Each isoform has yet to be studied indepen-dently in detail, but it is likely that the shortest 56 kDa isoform plays a distinct role or has a unique set of targets, based on its lack of the TUDOR domain. The presence of a TUDOR domain is not found in other PRC2-interacting pro-teins such as JARID2, AEBP2, YY1 or RBBP4, and this may confer a unique role to PCL2.

The recruitment process has been well studied in Drosophila and Polycomb Response Elements (PREs) have been iden-tified as locations on DNA to which PRC2 members are recruited. Invertebrate PREs are not simply one conserved sequence, but contain multiple PHO, Zeste and GAGA binding sites (reviewed in ref. 20). Despite the abundance of genome-wide promoter occupancy data for each of the PRC2 proteins, identification of analo-gous PREs in mammalian cells has proven unsuccessful. One potential mammalian targeting factor is YY1 (PHO homolog) and two groups have recently reported the identification of regions of mammalian DNA containing multiple YY1 binding sites which are capable of regulating PcG complex binding and gene repression.21,22 Only two such instances have been iden-tified; thus, it is difficult to decipher any rules for mammalian PREs or conclude whether this is a general mechanism of recruitment. With increased data support-ing the association between the core PRC2 complex members and multiple accessory proteins such as PCL2, JARID2, AEBP2, YY1, RBBP4, RBB7 and STK38, the assembly of the complex may be dynamic, and recruitment of PRC2 may be varied depending on the target.

Attempts to characterize a consensus binding sequence for JARID2 revealed only that the binding regions tended to be GC-rich,12,14,23 an observation previously noted based on PRC2 binding profiles.24 Thus, it was suggested that JARID2 binds DNA without clear sequence specific-ity, an outcome that will not facilitate the prediction or further the mechanistic understanding of PRC2 recruitment and binding to its targets. In-depth data min-ing of PCL2 targets may indicate whether binding of PCL2 is more restrictive than JARID2.



work in drafting a PRC2 GRN. By inte-grating transcriptome and ChIP-seq data, we have determined that PCL2 and other members of core PRC2 are integrated into the pluripotency network.

Through our work on the PCL2-PRC2 GRN, we have seen that the depletion of PCL2 results in upregulation of key TF nodes, such as Tbx3, Klf4 and Foxd3, which are known to support self-renewal through the stabilization of OCT4/SOX2/NANOG pluripotency network. This connection is highly significant because each of these genes is activated by OCT4 or NANOG. Even more importantly, TBX3, KLF4 and FOXD3 have been shown to contribute to the stabilization of the self-renewal network through feed-back mechanisms.32-34 We propose that in wild type cells, repression of Tbx3, Klf4 and Foxd3 from PCL2-PRC2 tempers the self-renewal network so that cells are able to respond to external stimuli (Fig. 2). As can be seen in the Pcl2 knockdown ESC lines, without this internal control mech-anism the increase in TBX3, KLF4 and FOXD3 drives the continued expression of Oct4, Nanog and Sox2, despite the with-drawal of LIF from the media. Consistent with our GRN model, overexpression of TBX3 or KLF4 has been shown to sup-port the pluripotency network even in the absence of LIF.35 Our GRN model suggests that a lack of the PRC2 complex prevents histone modification of the pro-moters of downstream pluripotency fac-tors (e.g., Tbx3, Klf4, Foxd3). In turn, the increased expression of these pluripotency TFs leads to increased transcriptional activation the core pluripotency network of Oct4, Nanog and Sox2, even in the pres-ence of external stimuli signalling differ-entiation (Fig. 2). The dominant effect of the core pluripotency GRN nodes, such as Oct4 and Sox2 is evident in current meth-ods of reprogramming. Reactivation of the pluripotency GRN by forced expres-sion of Oct4, Sox2, Klf4 and c-Myc is able to reprogram terminally-differentiated cells into pluripotent cells (i.e., induced pluripotent stem cells or (iPSCs) in both mouse and human.36,37

We propose that the PRC2 complex, along with PCL2 and JARID2, plays a key role during the short time window when ESCs become committed progenitors. To

self-renewal. Instead, the importance of these PcG proteins appears to be dur-ing exit from the pluripotent state, with absence of any one component resulting in delayed downregulation of Oct4, Nanog and Sox2 during early differentiation. It is this delayed downregulation of the pluri-potency network, along with delayed or incomplete upregulation of developmen-tal targets which causes failure to develop into more specialized cell types.

Association with the PRC2 Gene Regulatory Network

To better understand the molecular role of PCL2 in self-renewal and early dif-ferentiation, we performed genome-wide transcriptome analyses of Pcl2 knock-down ESCs. We then we performed ChIP-seq to comprehensively map genome-wide PCL2 binding in ESCs. Gene ontology analyses of both our tran-scriptome and promoter occupancy data demonstrated that proteins regulated by PCL2 function in various developmental processes such as differentiation and pat-tern specification and include a high pro-portion of TFs. We compared our PCL2 ChIP-seq data to available PRC2 ChIP-seq datasets24 and found that many PCL2 targets overlap with those of SUZ12 and EZH2. By combining transcriptome and promoter occupancy data, we were able to draft the PCL2-PRC2 gene regulatory network, which includes many develop-mental targets controlling differentiation into all three germ layers. Interestingly, approximately 50% of the top 1,000 PCL2 targets are bound by JARID2,12 supporting the possibility that JARID2 and PCL2 may both associate with the PRC2 complex at a subset of specific targets.

A GRN Model of PRC2 Function through Epigenetic Modification

We propose an updated model of PRC2 function in ESCs, incorporating recent data, particularly from analysis of the newly described PRC2 accessory proteins PCL2 and JARID2. A compelling expla-nation for the gene expression profiles and resulting phenotype of PRC2 member depleted ESCs comes as a result of our

true, one would expect that depletion of a PRC2 component would diminish the self-renewing status of the ESC, resulting in upregulation of target gene expression and increased differentiation. To identify the role of PCL2 in ESCs, we performed loss-of-function assays in mouse ESCs. Interestingly, downregulation of Pcl2 resulted in maintenance of high levels of Oct4 throughout the time course of dif-ferentiation as measured by high-content imaging.5 Clonogenic assays demonstrated that a higher proportion of single Pcl2 knockdown cells formed undifferentiated colonies compared to wild-type and con-trol knockdown ESCs.

Concomitant with increased self-renewal, depletion of PCL2 resulted in impaired differentiation capacity of ESCs. In a short-term monolayer neu-roectoderm differentiation assay, Pcl2 knockdown cells failed to express Nestin and maintained high levels of OCT4. To evaluate whether the delay in differentia-tion is temporal or absolute, we generated embryoid bodies (EBs) from Pcl2 knock-down ESCs. While control EBs formed differentiated cells expressing proteins of all three germ layers, Pcl2 knockdown EBs were small, generated very few differenti-ated cells, never formed cystic structures, and did not express markers of the endo-derm. Pcl2 knockdown EB outgrowths from day 8 cultures continued to express OCT4 robustly and outgrowths from day 25 cultures formed undifferentiated ALP + colonies. Together these phenotypic data suggest that PCL2 is a critical regulator of ESC fate decisions and lack of PCL2 con-tributes to a delay in differentiation and maintenance of a population of cells with ESC-like characteristics.

A similar phenotype has been observed in knockout or knockdown experiments using other PRC2 complex members, including Suz12,29 Ezh2,30 and Eed.31 JARID2, a member of the Jumonji family of histone methyltransferases and recently identified as a PRC2 accessory protein, has also demonstrated similar defects in differentiation of knockdown ESCs.13,14 In all cases, ESCs exhibited strong self-renewal characteristics and maintained normal levels of Oct4, Nanog and Sox2, demonstrating that PRC2 core and acces-sory proteins are dispensable for ESC



3meH3K4 activation mark on the pro-moters of Oct4 and Nanog over a 7 day differentiation time course, but display a delay in upregulation of 3meH3K27 at the same targets. More in-depth analysis of bivalent histone modifications on target genes during a time course of differentia-tion will help to delineate the role of vari-ous PRC2 components, including PCL2, during early commitment.

It has recently been shown that the downregulation of 3meH3K27 by PRC2 at particular sites is followed by an

PRC2 provides a delicate balance to pro-mote self-renewal but enable efficient cell commitment. Knockout or knockdown of PRC2 complex members or accessory pro-teins tips the scales, preventing the proper downregulation of the extended pluri-potency network and maintaining ESC self-renewal characteristics. A time course methylation analysis in Jarid2 ESCs pro-vides insight into what might be happen-ing to the pluripotency network during differentiation.12 Jarid2 knockdown ESCs maintain proper downregulation of the

properly transition during differentiation, ESCs must downregulate expression of the pluripotency network, while upregu-lating expression of developmental TFs. As the cell transitions from pluripotent to committed, Oct4, Nanog and Sox2 may rely on the repressive mark laid out by PRC2 to prevent widespread activa-tion of developmental genes while expres-sion of cell-type specific developmental TFs are established to appropriately and precisely activate/repress the plethora of genes available for expression. Thus, the

Figure 2. PCL2-PrC2-JariD2 gene regulatory network during early differentiation. in eSCs, promoters of PrC2 genes, including PCL2 and JariD2, carry the 3meH3K4 methylation mark and genes are highly expressed. PrC2 represses bivalent-marked members of the extended pluripotency network, Klf4, Foxd3 and Tbx3 which then act to induce transcription of the core pluripotency network (Oct4, Sox2, Nanog) via feed-forward mechanisms. High expression of the core and extended pluripotency network, along with PrC2 repression of developmental genes, maintains eSC self-renewal and plu-ripotency. During differentiation, the downregulation of Oct4, Sox2 and Nanog leads to the decreased expression of Klf4, tbx3, Foxd3 and PrC2 genes, and collapse of the pluripotency network. Developmental genes previously poised for activation, are now de-repressed due to the decreased expres-sion of PrC2. Loss of 3meH3K27 and increased expression of differentiation genes allows cells to become committed to various lineages. Methylation states are reflected in colour of gene boxes. For simplicity, gene expression levels are represented as protein expression levels, although this may not always reflect the true case. Dashed lines indicate potential interactions.



15. Kim TG, Kraus JC, Chen J, Lee Y. JUMONJI, a critical factor for cardiac development, functions as a transcriptional repressor. J Biol Chem 2003; 278:42247-55.

16. Klug A. Zinc finger peptides for the regulation of gene expression. J Mol Biol 1999; 293:215-8.

17. Matthews JM, Sunde M. Zinc fingers—folds for many occasions. IUBMB Life 2002; 54:351-5.

18. Li H, Ilin S, Wang W, Duncan EM, Wysocka J, Allis CD, et al. Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF. Nature 2006; 442:91-5.

19. Wysocka J, Swigut T, Xiao H, Milne TA, Kwon SY, Landry J, et al. A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature 2006; 442:86-90.

20. Schuettengruber B, Cavalli G. Recruitment of polycomb group complexes and their role in the dynamic regulation of cell fate choice. Development (Cambridge, England) 2009; 136:3531-42.

21. Sing A, Pannell D, Karaiskakis A, Sturgeon K, Djabali M, Ellis J, et al. A vertebrate Polycomb response element governs segmentation of the poste-rior hindbrain. Cell 2009; 138:885-97.

22. Woo CJ, Kharchenko PV, Daheron L, Park PJ, Kingston RE. A region of the human HOXD cluster that confers polycomb-group responsiveness. Cell 2010; 140:99-110.

23. Peng JC, Valouev A, Swigut T, Zhang J, Zhao Y, Sidow A, et al. Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells. Cell 2009; 139:1290-302.

24. Ku M, Koche RP, Rheinbay E, Mendenhall EM, Endoh M, Mikkelsen TS, et al. Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet 2008; 4:1000242.

25. Pasini D, Cloos PA, Walfridsson J, Olsson L, Bukowski JP, Johansen JV, et al. JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells. Nature 2010; 464:306-10.

26. Zhao J, Sun BK, Erwin JA, Song JJ, Lee JT. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 2008; 322:750-6.

27. Herz HM, Shilatifard A. The JARID2-PRC2 duality. Genes Dev 2010; 24:857-61.

28. Boyer LA, Plath K, Zeitlinger J, Brambrink T, Medeiros LA, Lee TI, et al. Polycomb complexes repress developmental regulators in murine embry-onic stem cells. Nature 2006; 441:349-53.

29. Pasini D, Bracken AP, Hansen JB, Capillo M, Helin K. The polycomb group protein Suz12 is required for embryonic stem cell differentiation. Mol Cell Biol 2007; 27:3769-79.

30. Shen X, Liu Y, Hsu YJ, Fujiwara Y, Kim J, Mao X, et al. EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. Molecular cell 2008; 32:491-502.

31. Chamberlain SJ, Yee D, Magnuson T. Polycomb repressive complex 2 is dispensable for maintenance of embryonic stem cell pluripotency. Stem Cells 2008; 26:1496-505.

32. Hanna LA, Foreman RK, Tarasenko IA, Kessler DS, Labosky PA. Requirement for Foxd3 in maintaining pluripotent cells of the early mouse embryo. Genes Dev 2002; 16:2650-61.

33. Ivanova N, Dobrin R, Lu R, Kotenko I, Levorse J, DeCoste C, et al. Dissecting self-renewal in stem cells with RNA interference. Nature 2006; 442:533-8.

34. Kim J, Chu J, Shen X, Wang J, Orkin SH. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 2008; 132:1049-61.

35. Niwa H, Ogawa K, Shimosato D, Adachi K. A paral-lel circuit of LIF signalling pathways maintains pluri-potency of mouse ES cells. Nature 2009; 460:118-22.

This work was supported by an operating grant from the Canadian Cancer Society Research Institute (19122) to W.L.S. E.W. and J.L.M. were both supported by CIHR Banting and Best CGS Doctoral Research Awards; W.Y.C. was supported by a Heart & Stroke Foundation of Canada Postdoctoral Fellowship; and W.L.S. was supported by a Canada Research Chair.

References1. Faust C, Schumacher A, Holdener B, Magnuson

T. The eed mutation disrupts anterior mesoderm production in mice. Development (Cambridge, England) 1995; 121:273-85.

2. O’Carroll D, Erhardt S, Pagani M, Barton SC, Surani MA, Jenuwein T. The polycomb-group gene Ezh2 is required for early mouse development. Mol Cell Biol 2001; 21:4330-6.

3. Pasini D, Bracken AP, Jensen MR, Lazzerini Denchi E, Helin K. Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity. EMBO J 2004; 23:4061-71.

4. Walker E, Ohishi M, Davey RE, Zhang W, Cassar PA, Tanaka TS, et al. Prediction and testing of novel transcriptional networks regulating embryonic stem cell self-renewal and commitment. Cell stem cell 2007; 1:71-86.

5. Walker E, Chang WY, Hunkapiller J, Cagney G, Garcha K, Torchia J, et al. Polycomb-like 2 associates with PRC2 and regulates transcriptional networks during mouse embryonic stem cell self-renewal and differentiation. Cell stem cell 2010; 6:153-66.

6. Wang S, Yu X, Zhang T, Zhang X, Zhang Z, Chen Y. Chick Pcl2 regulates the left-right asym-metry by repressing Shh expression in Hensen’s node. Development (Cambridge, England) 2004; 131:4381-91.

7. O’Connell S, Wang L, Robert S, Jones CA, Saint R, Jones RS. Polycomblike PHD fingers mediate conserved interaction with enhancer of zeste protein. J Biol Chem 2001; 276:43065-73.

8. Cao R, Wang H, He J, Erdjument-Bromage H, Tempst P, Zhang Y. Role of hPHF1 in H3K27 meth-ylation and Hox gene silencing. Mol Cell Biol 2008; 28:1862-72.

9. Nekrasov M, Klymenko T, Fraterman S, Papp B, Oktaba K, Kocher T, et al. Pcl-PRC2 is needed to generate high levels of H3-K27 trimethylation at Polycomb target genes. EMBO J 2007; 26:4078-88.

10. Sarma K, Margueron R, Ivanov A, Pirrotta V, Reinberg D. Ezh2 requires PHF1 to efficiently cata-lyze H3 lysine 27 trimethylation in vivo. Mol Cell Biol 2008; 28:2718-31.

11. Savla U, Benes J, Zhang J, Jones RS. Recruitment of Drosophila Polycomb-group proteins by Polycomblike, a component of a novel protein com-plex in larvae. Development (Cambridge, England) 2008; 135:813-7.

12. Li G, Margueron R, Ku M, Chambon P, Bernstein BE, Reinberg D. Jarid2 and PRC2, partners in regu-lating gene expression. Genes Dev 2010; 24:368-80.

13. Shen X, Kim W, Fujiwara Y, Simon MD, Liu Y, Mysliwiec MR, et al. Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. Cell 2009; 139:1303-14.

14. Landeira D, Sauer S, Poot R, Dvorkina M, Mazzarella L, Jorgensen HF, et al. Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulators. Nat Cell Biol 2010; 12:618-24.

upregulation of acetylation at H3K27, leading to transcriptional activation of target genes.38 Re-expression of SUZ12 in Suz12-/- cells restores 3meH3K27 methylation while decreasing H3K27Ac, supporting the notion that the PRC2 complex may play a role in preventing the accumulation of acetylation marks on particular histones. Histone deacety-lation may be mediated by the Mi2/NuRD complex, which contains multiple proteins including RBBP4 and RBBP7.39 In leukemic cells, it has been proposed that the coordinated recruitment of both the Mi-2/NuRD complex and PRC2 is needed for effective chromatin remod-elling and transcriptional repression.40 Mass spectrometry data on PCL2, EHZ2, SUZ12 and JARID2,5,12,13,25 has indicated an association of the components with RBBP4 and RBBP7, which suggests a link between PCL2-PRC2 methylation and NuRD deacetylation on chromatin in ESCs.

What about the large set of devel-opmental targets bound by PCL2? We observed that despite decreased levels of 3meH3K27 at their promoters in Pcl2 knockdown cells, targets were expressed at lower levels than in wild-type cells and showed a delay in upregulation during dif-ferentiation. We propose that this appar-ent contradiction is also explained by the reinforced activation of the self-renewal network. Many of the developmental tar-gets of PRC2 are also bound by OCT4, NANOG and SOX2. It is believed that these TFs repress such developmental targets either directly or through the extended pluripotency network. Thus, in Pcl2 knockdown cells, the increased repression exerted by the pluripotency network must override any transcriptional activation brought on by a decrease in 3meH3K27.

Thus, it is clear that the role of the PRC2 complex in controlling gene repres-sion is more dynamic than previously thought. With the wealth of recent data regarding new players PCL2 and JARID2, we have gathered much insight into the PRC2 but new questions have also been raised regarding how Polycomb repression of targets may be modulated by accessory proteins during ESC differentiation.

Acknowledgements



39. Denslow SA, Wade PA. The human Mi-2/NuRD complex and gene regulation. Oncogene 2007; 26:5433-8.

40. Morey L, Brenner C, Fazi F, Villa R, Gutierrez A, Buschbeck M, et al. MBD3, a component of the NuRD complex, facilitates chromatin alteration and deposition of epigenetic marks. Mol Cell Biol 2008; 28:5912-23.

36. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861-72.

37. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126:663-76.

38. Pasini D, Malatesta M, Jung HR, Walfridsson J, Willer A, Olsson L, et al. Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes. Nucleic Acids Res 2010; 38:4958-69.

PCL2 modulates gene regulatory networks controlling self-renewal and commitment in embryonic stem...

Documents

Transcript of PCL2 modulates gene regulatory networks controlling self-renewal and commitment in embryonic stem...